Target intelligence / Profile preview

RN7SK pseudogene 250 (RN7SKP250)

Target
RN7SKP250
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA) class (by analogy to parent gene function), Other (not a protein, not a typical drug target class)
01

Overview

RN7SK pseudogene 250 (RN7SKP250) is a non-coding RNA pseudogene related to the 7SK small nuclear RNA (RN7SK) family. Pseudogenes such as RN7SKP250 are generally considered to be genomic relics without an active biological or therapeutic function; they lack coding potential and are not involved in canonical signaling or enzymatic pathways. While parental RN7SK is important as a scaffold for the 7SK small nuclear ribonucleoprotein complex involved in negative regulation of transcription elongation by RNA polymerase II, there is no evidence that RN7SKP250 has a biological function, disease implication, or relevance as a therapeutic or drug target. Occasionally, some pseudogenes elsewhere in the genome have acquired regulatory functions (for example, as decoy lncRNAs), but there is no documentation supporting such a role for RN7SKP250. The designation RN7SKP250 likely reflects a systematic pseudogene naming convention and not a functional gene or protein. Its inclusion in therapeutic target lists is not supported, and it should not be considered a drug target.

Other names
RN7SKP250RNA, 7SK small nuclear pseudogene 250
02

Mechanism of action

None known (drugs do not act on pseudogenes)

03

Biological functions

None known for RN7SKP250By family analogy: regulation of transcription elongation (functional only in parental 7SK)
04

Disease associations

None established for RN7SKP250Some pseudogenes in this class (not this specific one) can act as lncRNAs influencing inflammation and transcriptional regulation
05

Safety considerations

None known (pseudogenes do not pose therapeutic safety concerns)
06

Interacting drugs

None known (pseudogenes are not drug targets)
07

Biomarkers

None known

Beyond the preview

Go deeper on RN7SK pseudogene 250 (RN7SKP250).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 250 (RN7SKP250).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call